| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 139.28B | 137.18B | 130.04B | 122.75B | 137.65B | 136.01B |
| Gross Profit | 40.66B | 37.91B | 37.20B | 35.16B | 36.77B | 35.87B |
| EBITDA | 8.05B | 7.98B | 6.99B | 4.17B | 7.49B | 5.00B |
| Net Income | 4.16B | 4.13B | 3.58B | 1.61B | 3.90B | 1.55B |
Balance Sheet | ||||||
| Total Assets | 59.92B | 57.70B | 52.18B | 47.34B | 48.69B | 47.21B |
| Cash, Cash Equivalents and Short-Term Investments | 15.61B | 13.46B | 12.69B | 9.04B | 11.58B | 10.62B |
| Total Debt | 14.56B | 12.75B | 11.80B | 11.64B | 12.19B | 13.42B |
| Total Liabilities | 32.69B | 30.84B | 28.91B | 27.28B | 29.14B | 30.95B |
| Stockholders Equity | 27.23B | 26.86B | 23.27B | 20.06B | 19.54B | 16.26B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.55B | 3.63B | -557.00M | 2.86B | 4.75B |
| Operating Cash Flow | 0.00 | 5.27B | 7.36B | 3.33B | 6.13B | 6.80B |
| Investing Cash Flow | 0.00 | -3.05B | -3.29B | -4.20B | -3.27B | -1.19B |
| Financing Cash Flow | 0.00 | -1.45B | -423.00M | -1.68B | -1.90B | -702.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥22.52B | 7.62 | ― | 4.11% | 8.87% | -17.91% | |
78 Outperform | ¥30.62B | 12.09 | ― | 1.94% | 3.15% | 27.71% | |
77 Outperform | ¥34.62B | 7.69 | ― | 1.93% | 6.11% | 15.68% | |
72 Outperform | ¥42.49B | 9.01 | ― | 3.82% | 3.39% | 29.30% | |
68 Neutral | ¥20.53B | 14.60 | ― | 2.06% | 2.66% | 1.00% | |
65 Neutral | ¥28.09B | 36.71 | ― | 3.23% | -0.31% | -37.42% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |